The Hypoactive Sexual Desire Disorder Treatment market was valued at USD 139.70 Million in 2022 and is expected to reach USD 191.20 Million by 2030, growing at a CAGR of 4% (2023-2030). Get insights on trends, segmentation, and key players with Data